Share on Pinterest Scientists have found a link between accelerated biological age and colon cancer risk. silkwayrain/Getty Images New research suggests that biological age — a measure of the ...
This is particularly true for colon cancer. If the disease is caught in its early stages, before symptoms develop, the five-year survival rate is an impressive 91%. Despite this, colorectal cancer ...
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...
Biocytogen’s fully human antibody will support the development of SOT109, SOTIO’s new ADC candidate aimed at the treatment of colorectal cancer and other gastrointestinal (GI) cancers.